186 related articles for article (PubMed ID: 7512174)
1. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
Siitonen T; Savolainen ER; Koistinen P
Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
3. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
4. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
5. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
6. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
7. [Study of the expression and function of c-kit receptor on the bone marrow mononuclear cells of the patients with myelodysplastic syndromes].
Zhang H; Shao Z; Chen G; Wang L; Zhang Y; Li K; Li L; Sun J; Hao Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):176-8. PubMed ID: 11876975
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J
Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
[TBL] [Abstract][Full Text] [Related]
9. Detection of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia.
Hsu HC; Tan LY; Au LC; Lee YM; Lieu CH; Tsai WH; You JY; Liu MD; Ho CK
J Lab Clin Med; 2004 Feb; 143(2):125-9. PubMed ID: 14966468
[TBL] [Abstract][Full Text] [Related]
10. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
11. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
12. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
deCastro CM; Denning SM; Langdon S; Vandenbark GR; Kurtzberg J; Scearce R; Haynes BF; Kaufman RE
Exp Hematol; 1994 Sep; 22(10):1025-33. PubMed ID: 7522182
[TBL] [Abstract][Full Text] [Related]
13. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
15. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
[TBL] [Abstract][Full Text] [Related]
16. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
[TBL] [Abstract][Full Text] [Related]
17. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE
Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
19. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
